Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020
CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010
Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004
Long–term follow-up of patients on sildenafil from Croatian pulmonary hypertension registry Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010
Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010
Long-term outcome with subcutaneous treprostinil sodium in pulmonary hypertension: a 10-year single-centre study Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009
French pulmonary arterial hypertension registry in children: 2-year follow-up data Source: Annual Congress 2009 - Pulmonary circulation Year: 2009
Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis Source: Eur Respir J 2013; 42: 134-144 Year: 2013
Acute effects, 1-year, and 2-year follow up of iloprost-aerosol therapy in severe primary pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001
Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
One-year observation of iloprost inhalation therapy in patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 324s Year: 2001
Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Pulmonary rehabilitation in COPD patients: a 3-year experience Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Source: Eur Respir J 2012; 39: 945-955 Year: 2012
Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Long-term outcomes of percutaneous coronary intervention in patients with chronic obstructive pulmonary disease: a 13-year nationwide cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017